Published in Br J Dermatol on October 01, 1987
Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis. Cancer Prev Res (Phila) (2012) 0.92
UVB radiation further stimulates proliferation in the already hyperproliferative epidermis of the asebia mouse. Arch Dermatol Res (1989) 0.77
Cyclosporin-A associated malignancy. Clin Ophthalmol (2007) 0.76
Skin tumours in renal allograft recipient. J R Soc Med (1989) 0.75
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58
Community treatment of end-stage renal failure by dialysis and renal transplantation from cadaver donors. Lancet (1969) 2.53
Controlled clinical trial of antilymphocyte globulin in patients with renal allografts from cadaver donors. Lancet (1971) 1.82
High-dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation (1997) 1.65
A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61
The effect of heterologous immune serum on canine renal homografts. Transplantation (1966) 1.52
Physiological changes during liver transplantation. Anaesth Intensive Care (1989) 1.43
Saphenous-vein arteriovenous fistula in regular dialysis treatment. N Engl J Med (1969) 1.42
Retrieval of organs for transplantation: experience of the Australian National Liver Transplantation Unit. Med J Aust (1996) 1.39
Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance. Transplantation (2001) 1.38
Cancer and survival after cadaveric donor renal transplantation. Transplant Proc (1979) 1.18
Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc (1985) 1.14
Cancer in renal allograft recipients in Australia and New Zealand. Transplant Proc (1977) 1.09
Immunologic relationships between skin and kidney homografts in dogs on immunosuppressive therapy. Transplantation (1966) 1.07
Cancer following successful cadaveric donor renal transplantation. Transplant Proc (1981) 1.05
Antilymphocyte globulin in patients with renal allografts from cadaveric donors. Late results of a controlled trail. Lancet (1973) 1.04
Reversal of renal failure by revascularisation of kidneys with thrombosed renal arteries. Lancet (1973) 1.03
Deaths from occlusive arterial disease in renal allograft recipients. Br Med J (1974) 1.01
Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int (1986) 1.01
Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation (1995) 1.00
A controlled clinical trial of machine perfusion of cadaveric donor renal allografts. Lancet (1975) 0.98
Aortic occlusion and vascular isolation allowing avascular hepatic resection. Arch Surg (1990) 0.98
Bone loss after liver transplantation. Hepatology (1991) 0.97
Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation (1999) 0.97
Renal autotransplantation for severe loin-pain/haematuria syndrome. Lancet (1985) 0.95
Twenty and 25 years survival after cadaveric renal transplantation. Transplant Proc (1995) 0.94
Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol (1992) 0.93
Effects of ultraviolet radiation and immunosuppressive therapy on mouse epidermal cell kinetics. Br J Dermatol (1986) 0.92
The living, related kidney donor: a follow-up study. Med J Aust (1988) 0.91
Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol (1996) 0.91
Bilateral nephrectomy for malignant hypertension. Lancet (1972) 0.90
Immunoglobulin abnormalities in renal transplant recipients. Transplantation (1989) 0.90
The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol (1994) 0.90
Primary graft dysfunction after liver transplantation. Transplant Proc (2000) 0.88
Cancer in patients treated with immunosuppressive drugs. Br Med J (Clin Res Ed) (1981) 0.88
Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: early activation and apoptosis is associated with liver graft acceptance. Transplantation (1998) 0.88
Giant cavernous haemangioma: a rare indication for liver transplantation. Aust N Z J Surg (1996) 0.88
Hepatic resection with vascular isolation and routine supraceliac aortic clamping. Am J Surg (1996) 0.87
Cryopreserved porcine hepatocytes in a liver biodialysis system. Transplant Proc (2001) 0.87
Embolic and ischemic complications after anastomosis of radial artery to cephalic vein. Surgery (1969) 0.87
Orthotopic liver transplantation for treatment of patients with Budd-Chiari syndrome: a Singe-center experience. Transplant Proc (2000) 0.86
Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. Cell Transplant (1999) 0.86
Cryopreservation of primary porcine hepatocytes for use in bioartificial liver support systems. Transplant Proc (2000) 0.86
Cancer after transplantation. World J Surg (1986) 0.86
Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin. Am J Surg Pathol (1984) 0.86
Fulminant hepatic failure and liver transplantation. Transplant Proc (1992) 0.86
Cadaveric liver procurement using aortic perfusion only. Aust N Z J Surg (1998) 0.85
Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation (1994) 0.85
Biochemical aspects of experimental hepatic allotransplantation. Arch Surg (1974) 0.84
Allograft vein arterial bypass. Arch Surg (1978) 0.84
Serious arterial complications following removal of failed renal allografts. Med J Aust (1971) 0.84
Kidney preservation for transportation. IV. Eight-thousand-mile international air transport. Aust N Z J Surg (1970) 0.84
Tissue matching and early rejection of cadaveric-donor renal allografts: the importance of unidentified donor antigens. Br Med J (1970) 0.84
Postreperfusion syndrome in orthotopic liver transplantation. Transplant Proc (2000) 0.83
Incidence of cancer in renal transplant recipients. Proc Eur Dial Transplant Assoc (1980) 0.83
Cancer following renal transplantation. Aust N Z J Surg (1979) 0.83
Tolerance to rat liver allografts: IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation (1996) 0.83
Simple and reliable methods to assess hepatocyte viability in bioartificial liver support system matrices. Artif Organs (1997) 0.82
Factors affecting hepatocyte viability and CYPIA1 activity during encapsulation. Artif Cells Blood Substit Immobil Biotechnol (2000) 0.82
Biliary strictures after liver transplantation: clinical picture, correlates and outcomes. J Gastroenterol Hepatol (1996) 0.82
Aorto-intestinal fstulas following operations on the abdominal aorta and iliac arteries. Br J Surg (1969) 0.82
Cancer risk associated with ATG/OKT3 in renal transplantation. Transplant Proc (1999) 0.81
Liver transplantation in patients with transjugular intrahepatic portosystemic shunts. Transplant Proc (2000) 0.81
Limitations of human umbilical vein grafts. Surgery (1984) 0.81
ABO blood group incompatibility in renal transplantation. Transplantation (1969) 0.81
Recurrence of cancer after renal transplantation. Transplant Proc (2001) 0.81
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin. Liver Transpl Surg (1999) 0.81
A comparison of the effects of cyclosporin A and standard agents on primary wound healing in the rat. Surg Gynecol Obstet (1985) 0.81
Failure of liver transplantation in Wilson's disease with pulmonary arteriovenous shunting. J Pediatr Gastroenterol Nutr (1990) 0.81
Vascular complications following orthotopic liver transplantation. Aust N Z J Surg (1990) 0.81
A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling. Hepatology (1990) 0.81
Delayed complications of renal transplantation and their prevention. Med J Aust (1982) 0.80
E-rosette forming cell numbers in the blood of human renal allograft recipients. Clin Exp Immunol (1977) 0.80
Renal transplantation from cadaver donors. Med J Aust (1968) 0.80
Liver transplantation in patients with transjugular intrahepatic portosystemic shunts. Aust N Z J Surg (2000) 0.80
Human liver allograft rejection: severity, prognosis, and response to treatment. Transplant Proc (1989) 0.80
Clinical organ transplantation. Transplant Proc (1987) 0.80
A large, single center investigation of the immunogenetic factors affecting liver transplantation. Transplantation (2000) 0.80
Pneumocystis carinii pneumonia after liver transplantation in adults. Clin Transplant (1994) 0.80
Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome. J Gastroenterol Hepatol (1993) 0.80
Successful renal allotransplantation in presence of lymphocytotoxic antibodies. Importance of preoperative cross-matching. Lancet (1969) 0.80
Antilymphocyte serum: a review with report of the current clinical situation in Australia. Med J Aust (1969) 0.80
Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report. Transplant Proc (1999) 0.79
Cadaveric donor renal transplantation. Med J Aust (1972) 0.79
Small arterial reconstruction using modified cadaveric saphenous veins. Am J Surg (1977) 0.79
Synergistic effect of Tripterygium wilfordii Hook.F (TWHF) and cyclosporin A in rat liver transplantation. Transplant Proc (2000) 0.79
Prognostic value of intraoperative blood-flow measurements in femoropopliteal bypass vein-grafts. Lancet (1968) 0.79
The role of CMV immune prophylaxis in patients at risk of primary CMV infection following orthotopic liver transplantation. Transplant Proc (1989) 0.79
Donor fatty (steatotic) liver allografts in orthotopic liver transplantation: a revisit. Transplant Proc (2000) 0.79
A modified technique for orthotopic liver transplantation. Arch Surg (1972) 0.79
FK 506 and orthotopic liver transplantation in the rat. Transplant Proc (1990) 0.78
Reversal of renal failure and control of hypertension in patients with occlusion of the renal artery. Surg Gynecol Obstet (1976) 0.78
An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified? Clin Transplant (1999) 0.78
Identification of the cellular subpopulations infiltrating rejecting cadaver renal allografts. Preponderance of the T4 subset of T cells. Transplantation (1984) 0.78
Temporary wound closure with expanded polytetrafluoroethylene in pediatric liver transplantation. Clin Transplant (1992) 0.78
Peritoneal morphology on maintenance dialysis. Am J Nephrol (1989) 0.78
Autogenous veins and velour dacron in femoropopliteal arterial bypass. Surgery (1977) 0.78
Case report: delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis. J Gastroenterol Hepatol (1996) 0.78